This inventor holds 5 USPTO granted patents. Top assignees: University of Illinois, Chicago Biosolutions, Inc.. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019-2023
Title: The Innovative Contributions of Irina Gaisina
Introduction
Irina Gaisina is a prominent inventor based in Berwyn, IL (US), known for her significant contributions to the field of medical research. With a total of 5 patents to her name, she has made strides in developing therapeutic options for various health conditions, particularly in the realm of viral infections and cancer treatment.
Latest Patents
One of her notable patents focuses on "Inhibitors of influenza viral entry." This invention addresses the urgent need for effective treatments for seasonal influenza infections, which often require a lengthy vaccine development process. Gaisina's work describes fast-acting, orally active acylated amino-substituted heterocyclyl compounds that can effectively control the influenza virus. Another significant patent involves "HDAC inhibitors and therapeutic methods using the same." This patent outlines the use of histone deacetylase inhibitors (HDACIs) for treating various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.
Career Highlights
Throughout her career, Gaisina has worked with esteemed organizations such as the University of Illinois and Chicago Biosolutions, Inc. Her research has not only contributed to scientific knowledge but has also paved the way for new therapeutic approaches in medicine.
Collaborations
Irina Gaisina has collaborated with notable colleagues, including Alan P Kozikowski and Lijun Rong. These partnerships have enhanced her research efforts and expanded the impact of her inventions.
Conclusion
Irina Gaisina's innovative work in developing treatments for influenza and other serious health conditions showcases her dedication to advancing medical science. Her contributions continue to influence the field and offer hope for improved therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile